The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals.

Here's where Dr. David Eifrig says to move your money immediately.

Jon K. Hayashida net worth and biography

Jon Hayashida Biography and Net Worth

VP of STAAR Surgical

Dr. Jon K. Hayashida joined STAAR in July 2015 as Vice President of Global Clinical and Medical Affairs. Over the past 30 years, Dr. Hayashida's professional career includes experience in corporate eye care, ophthalmic start-up companies and direct patient care. From 2010 to 2013 he held the position of Vice President of Clinical and Medical Affairs for Bausch and Lomb, Surgical, where he gained FDA approvals for both the Glistening-free enVista Hydrophobic Acrylic IOL and PMA approval for the Trulign Toric Accommodating IOL. He also held Clinical Affairs leadership and research positions with Cooper Vision and Allergan. His Ophthalmic start-up company experience includes Vice President Clinical Affairs for Wavetec Vision, Transcend Medical and Refractec where he directed, planned and executed successful FDA PMA approvals. Dr. Hayashida has served as a clinical care specialist at the UCLA Laser Refractive Center, Jules Stein Institute, UCLA School of Medicine. Most recently, from 2013 to 2015, he served as Vice President of Programs and Services for the Braille Institute of America. He earned his Bachelor of Science and Doctorate of Optometry from Southern California College of Optometry. Dr. Hayashida is a Fellow of the American Academy of Optometry and a Diplomate in its Cornea and Contact Lens and Refractive Technologies Section.

What is Jon K. Hayashida's net worth?: The estimated net worth of Jon K. Hayashida is at least $455,089.36 as of March 22nd, 2021. Dr. Hayashida owns 9,691 shares of STAAR Surgical stock worth more than $455,089 as of April 26th. This net worth approximation does not reflect any other assets that Dr. Hayashida may own. Learn More about Jon K. Hayashida's net worth.
How do I contact Jon K. Hayashida?: The corporate mailing address for Dr. Hayashida and other STAAR Surgical executives is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. STAAR Surgical can also be reached via phone at (626) 303-7902 and via email at [email protected]. Learn More on Jon K. Hayashida's contact information.
Has Jon K. Hayashida been buying or selling shares of STAAR Surgical?: Jon K. Hayashida has not been actively trading shares of STAAR Surgical during the last ninety days. Most recently, Jon K. Hayashida sold 1,103 shares of the business's stock in a transaction on Monday, March 22nd. The shares were sold at an average price of $96.37, for a transaction totalling $106,296.11. Following the completion of the sale, the vice president now directly owns 9,691 shares of the company's stock, valued at $933,921.67. Learn More on Jon K. Hayashida's trading history.
Who are STAAR Surgical's active insiders?: STAAR Surgical's insider roster includes Hans-Martin Blickensdoerfer (VP), James Francese (VP), Samuel Gesten (Insider), Graydon Hansen (VP), Jon Hayashida (VP), Keith Holliday (CTO), Caren Mason (CEO), and Patrick Williams (CFO). Learn More on STAAR Surgical's active insiders.
Are insiders buying or selling shares of STAAR Surgical?: During the last twelve months, STAAR Surgical insiders bought shares 19 times. They purchased a total of 1,279,304 shares worth more than $44,056,133.46. The most recent insider tranaction occured on March, 14th when Director Aimee S Weisner bought 1,750 shares worth more than $66,692.50. Insiders at STAAR Surgical own 1.1% of the company. Learn More about insider trades at STAAR Surgical.
Information on this page was last updated on 3/14/2024.

Jon K. Hayashida Insider Trading History at STAAR Surgical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/22/2021	Sell	1,103	$96.37	$106,296.11	9,691
11/9/2020	Sell	20,000	$81.34	$1,626,800.00	20,994
8/10/2020	Sell	41,602	$51.22	$2,130,854.44	27,000
5/11/2020	Sell	46,563	$39.11	$1,821,078.93	32,088
3/23/2020	Sell	2,813	$26.83	$75,472.79	13,607
12/5/2019	Sell	47,408	$37.20	$1,763,577.60	53,658

Jon K. Hayashida Buying and Selling Activity at STAAR Surgical

STAAR Surgical Company Overview

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Today's Range

Now: $46.96

$46.43

$48.02

50 Day Range

MA: $39.86

$30.39

$52.25

2 Week Range

Now: $46.96

$26.66

$73.13

Volume

335,626 shs

Average Volume

744,888 shs

Market Capitalization

$2.29 billion

P/E Ratio

109.21

Dividend Yield

N/A

Beta

0.86

Move Your Money Before May 22

From Stansberry Research | Ad